| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697062 | Brachytherapy | 2017 | 12 Pages |
Abstract
There has been a concerning decline in the utilization of BB for intermediate- and high-risk prostate cancer patients despite an association with improved on overall survival. Numerous factors predictive for use of BB have been identified.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S.M. Glaser, M.J. Dohopolski, G.K. Balasubramani, R.M. Benoit, R.P. Smith, S. Beriwal,